MMMNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
3M CO
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 20, 2026
$162.01−2.74 (-1.66%)
Close on Oct 19, 2026
- Market cap
- $84.63B
- P/E (TTM)
- 28.8
- Dividend yield
- 1.80%
Share price
+$9.37 (+6.14%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
3M CO grew revenue 2.3% to $25.18B over the twelve months to Jun 30, 2026. Operating income fell 3.4% to $4.62B, moving the operating margin from 19.5% to 18.4%. Free cash flow was $3.99B.
Revenue
$25.18B
+2.3% vs. a year earlier
Operating income
$4.62B
-3.4% vs. a year earlier
Free cash flow
$3.99B
TTM Q2 2026
EPS, diluted
$5.63
-21.7% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $84.63B
- P/E ratio
- 28.8
- Price to sales
- 3.36
- Price to book
- 28.67
- Dividend yield
- 1.80%
- Free cash flow yield
- 4.71%
Fundamentals
- Revenue
- $25.18B
- Net income
- $3.00B
- EPS, diluted
- $5.63
- Free cash flow
- $3.99B
- Book value per share
- $5.65
- Diluted shares
- 522M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$25.18B+2.3% YoY
Gross profit
$9.92B-1.6% YoY
Operating income
$4.62B-3.4% YoY
Net income
$3.00B-23.9% YoY
EPS, diluted
$5.63-21.7% YoY
Free cash flow
$3.99B
Reported periodTrailing twelve months